Page last updated: 2024-10-31

midazolam and Fuchs' Endothelial Dystrophy

midazolam has been researched along with Fuchs' Endothelial Dystrophy in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Fuchs' Endothelial Dystrophy: Disorder caused by loss of endothelium of the central cornea. It is characterized by hyaline endothelial outgrowths on Descemet's membrane, epithelial blisters, reduced vision, and pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oberg, TJ1
Sikder, S1
Jorgensen, AJ1
Mifflin, MD1

Other Studies

1 other study available for midazolam and Fuchs' Endothelial Dystrophy

ArticleYear
Topical-intracameral anesthesia without preoperative mydriatic agents for Descemet-stripping automated endothelial keratoplasty and phacoemulsification cataract surgery with intraocular lens implantation.
    Journal of cataract and refractive surgery, 2012, Volume: 38, Issue:3

    Topics: Administration, Topical; Analgesics; Anesthesia, Local; Anesthetics, Local; Anterior Eye Segment; De

2012